Elutia Inc. financial data

Symbol
ELUT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
12510 Prosperity Drive, Suite 370, Silver Spring, MD
State of incorporation
DE
Fiscal year end
December 31
Former names
AZIYO BIOLOGICS, INC. (to 8/14/2023)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 76.5 % -22.5%
Quick Ratio 8.5 % -53%
Debt-to-equity -187 % +57.7%
Return On Equity 112 % -42.9%
Return On Assets -128 % -124%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 15M USD -51.8%
Weighted Average Number of Shares Outstanding, Basic 32.5M shares +91.1%
Weighted Average Number of Shares Outstanding, Diluted 35.5M shares +109%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 4.33M USD +4.86%
Selling and Marketing Expense 12.2M USD -11.4%
General and Administrative Expense 18.2M USD +38.9%
Operating Income (Loss) -35.7M USD -7.81%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -60.3M USD -79.4%
Income Tax Expense (Benefit) -3K USD -109%
Net Income (Loss) Attributable to Parent -54.2M USD -60.4%
Earnings Per Share, Basic -2.21 USD/shares -6.76%
Earnings Per Share, Diluted -2.57 USD/shares -24.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 25.7M USD +77.3%
Accounts Receivable, after Allowance for Credit Loss, Current 2.93M USD +1.67%
Inventory, Net 3.63M USD -44.1%
Assets, Current 37.3M USD -4.62%
Property, Plant and Equipment, Net 693K USD +296%
Operating Lease, Right-of-Use Asset 1.4M USD
Intangible Assets, Net (Excluding Goodwill) 9.12M USD -27.1%
Other Assets, Noncurrent 1.27M USD +721%
Assets 48.4M USD -11.3%
Accounts Payable, Current 5.07M USD +71.3%
Accrued Liabilities, Current 5.43M USD -49.4%
Liabilities, Current 39.7M USD -11.3%
Operating Lease, Liability, Noncurrent 711K USD
Other Liabilities, Noncurrent 1.56M USD +259%
Liabilities 88.6M USD +5.46%
Retained Earnings (Accumulated Deficit) -221M USD -32.6%
Stockholders' Equity Attributable to Parent -40.2M USD -36.5%
Liabilities and Equity 48.4M USD -11.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.64M USD +48.9%
Net Cash Provided by (Used in) Financing Activities -4.07M USD -2849%
Net Cash Provided by (Used in) Investing Activities -15K USD +91.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 25.7M USD +77.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.54M USD +344%
Deferred Tax Assets, Valuation Allowance 39M USD +22.4%
Deferred Tax Assets, Gross 39.5M USD +20.6%
Operating Lease, Liability 1.4M USD
Payments to Acquire Property, Plant, and Equipment 15K USD -91.8%
Lessee, Operating Lease, Liability, to be Paid 281K USD +18.6%
Property, Plant and Equipment, Gross 753K USD -9.28%
Operating Lease, Liability, Current 275K USD +18.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 700K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 600K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6K USD +20%
Lessee, Operating Lease, Liability, to be Paid, Year Three 100K USD
Deferred Tax Assets, Operating Loss Carryforwards 23.3M USD +18.1%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 180M USD +31.7%
Amortization of Intangible Assets 3.4M USD +0.03%
Depreciation, Depletion and Amortization 864K USD -8.77%
Share-based Payment Arrangement, Expense 7.19M USD +176%
Interest Expense 5.68M USD +6.49%